Showing results (421-430 of 693) with videos related to
Sort By:
Pageof 70
Chinese Clinical Oncology|May 10, 2017
Evaluation of miR-22 and miR-20a as diagnostic biomarkers for gastric cancerZahra Jafarzadeh-Samani, Sareh Sohrabi, Khadije Shirmohammadi, et al.Chinese Clinical Oncology|May 10, 2017
Advances in evidence-based cancer adoptive cell therapyChunlei Ge, Ruilei Li, Xin Song, et al.Chinese Clinical Oncology|May 10, 2019
Inflammation and development of pancreatic ductal adenocarcinomaJuanjuan Shi, Jing XueChinese Clinical Oncology|May 10, 2019
Current treatment status in pancreatic neuroendocrine neoplasmsDe-Jun Liu, Rong Hua, Yong-Wei SunChinese Clinical Oncology|March 8, 2022
Genetic landscape of pancreatic cancer: a narrative reviewDidem Öncel Yakar, Bahadır Osman Bozkırlı, Güralp Onur CeyhanChinese Clinical Oncology|March 8, 2022
"Mitigation strategies for post-operative pancreatic fistula after pancreaticoduodenectomy in high-risk pancreas: an evidence-based algorithmic approach"-a narrative reviewAmir M Parray, Vikram A Chaudhari, Shailesh V Shrikhande, et al.Chinese Clinical Oncology|March 2, 2019
Systemic therapy of cutaneous T-cell lymphoma (CTCL)Onder Alpdogan, Saritha Kartan, William Johnson, et al.Chinese Clinical Oncology|July 18, 2019
The value of networks in driving phase I trials: the Peter MacCallum Cancer Centre experienceJayesh Desai, Christina Guo, Ben TranChinese Clinical Oncology|August 27, 2017
Updated response assessment criteria for high-grade glioma: beyond the MacDonald criteriaMayur Sharma, Rupa Gopalan Juthani, Michael A VogelbaumChinese Clinical Oncology|September 27, 2015
Statistical principles for omics-based clinical trialsMichael C SachsPageof 70